Health Care Blog

The researchers at the Massachusetts General Hospital have developed a method that will help the doctors to identify minute amounts of tumor cells floating in the blood of cancer patients. Thus the discovery is expected to lead to better treatments with fewer side effects.

The British research shows that the antiretroviral medications have helped to lower the death rate among the HIV patients down. For most, the five-year, post-diagnosis survival for those infected sexually is now about equal to that of the general population. Dramatic declines in death rates for HIV-infected individuals following the introduction of highly active antiretroviral [...]

Thousands of people have died and many others left homeless when the cyclone Nargis hit the Irrawaddy delta in Rangoon valley recently. But for the HIV/AIDS patients it was a worse nightmare as the cyclone has put them into more physical and mental agony. As a result of the devastation, more and more [...]

According to the researchers, people having HIV have much higher risk of cancer including anal cancer and low risk of prostate cancer.

Kristin Elliott, is 18 and suffering from cancer for last 2 years. But what made her special, is the wish she had made to the make a wish foundation– an orphanage for children in Africa. Even the make a wish officials confessed to have such a request for the first time.

In a move that has stunned HIV experts, German scientists reported yesterday that they had engineered an enzyme that attacked the DNA of the HIV virus, and cut it out of the infected cell.

Patients infected with both hepatitis B and HIV should not take the hepatitis-fighting drug Baraclude on its own, new research confirms.

GenVec, Inc. (Nasdaq: GNVC), announced today that the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has begun a Phase I clinical trial to test a novel vaccine known as Ad35HIV-EnvA to prevent HIV-1 infection.

amfAR, The Foundation for AIDS Research, will grant almost $1.2 million for 10 new research projects aimed at increasing understanding of the social and biological factors that influence the treatment of HIV/AIDS, Dr. Rowena Johnston, amfAR’s vice president of research.

Researchers have known that some primates, such as macaques, can fight off HIV with an antiviral protein called TRIM5-alpha, whereas the human version, though only slightly different, cannot combat HIV.